IATI Biomed 2016 Conference Program has nine main tracks consisting of invited Lectures/Panels and company presentations.
Trending topics have been identified and through this focused track approach, participants have the opportunity to gain a deeper understanding and more insight into the subjects.
IATI Biomed 2016 Conference tracks are:
- The Promise of Immuno-oncology
- Neurological Disorders
- Personalized Diagnostics and Precision Medicine
- Listen to your Aching Heart
- Health IT
- Early Stage Challenges and Opportunities
- Robotics’ Role in Healthcare
- The New “Kids” on the block
* Microbiome
* Gene Editing and Gene Therapy - From Academia Research to Industry
PRELIMINARY. ALL TIME SLOTS WITHIN TRACKS ARE SUBJECT TO CHANGE.
| WEDNESDAY, MAY 25, 2016 | |
| 08:00-16:00: | Registration Open |
| 09:30-10:10: | Keynote Lecture: Bruce R. Rosengard, MD, Chief Medical Science and Technology Officer, Johnson & Johnson Medical Device Companies |
| Bruce R. Rosengard, MD, Chief Medical Science and Technology Officer, Johnson & Johnson Medical Device Companies | |
| 10:10 - 10:40 | Coffee Break |
| 10:40 - 17:45: | Personalized Diagnostics and Precision Medicine Hall A |
| Chairpersons: Patrick Terry, President, GMPO Orphan and Dr. Eran Eden, PhD, CEO and Co-Founder, MeMed Diagnostics Ltd. | |
| 10:40 - 11:20: | Patrick Terry, President, GMPO Orphan - "Percision Medicine - Then and Now" |
| 11:20 - 12:00: | Dr. Eran Eden, PhD, CEO and Co-Founder, MeMed Diagnostics Ltd. - ''Opportunities and Challenges in Personalized Diagnostics - A Journey from an Idea to the Patient Bedside'' |
| 12:00 - 12:15: | NovellusDx Ltd. |
| 12:15 - 12:30: | ImmunArray Ltd. |
| 12:30 - 12:45: | LabStyle Innovations Corp. |
| 12:45 - 13:00: | CureWize Health Ltd. |
| 13:00-14:00: | Lunch Break |
| 14:00 - 14:15: | Hide and Seq |
| 14:15 - 14:30: | Medasense Biometrics Ltd. |
| 14:30 - 14:45: | Sight Diagnostics, Ltd. |
| 14:45 - 15:25: | Manish Kohli, MD, Mayo Clinic - “Applications of Genomic Sciences in Advanced Stage Prostate and Kidney cancer: Opportunities and Challenges in 2016” |
| 15:25 - 16:05: | Miro Venturi, PhD, Global Head Diagnostics Biomarkers, Hoffmann-la Roche - "The importance of diagnostics and molecular information in the patient's journey: realizing the promise of personalized healthcare" |
| 16:05 - 16:45: | Harry Glorikian, Entrepreneur in Residence, GE - ''The Future of Precision Medicine'' |
| 16:45 - 17:45: | Panel Discussion: Panelists: Patrick Terry, President, GMPO Orphan Dr. Eran Eden, PhD, CEO and Co-Founder, MeMed Diagnostics Ltd. Manish Kohli, MD, Mayo Clinic Miro Venturi, PhD, Global Head Diagnostics Biomarkers, Hoffmann-la Roche Harry Glorikian, Entrepreneur in Residence, GE |
| WEDNESDAY, MAY 25, 2016 | |
| 08:00-16:00: | Registration Open |
| 09:30-10:10: | Keynote Lecture: Bruce R. Rosengard, MD, Chief Medical Science and Technology Officer, Johnson & Johnson Medical Device Companies |
| 10:10 - 10:40: | Coffee Break |
| 10:40 - 17:40: | Listen to Your Aching Heart Hall B |
| 10:40 - 10:50: | Chairperson: Dr. Ehud Cohen, CEO BioControl |
| 10:50 - 11:30: | Donald E. Bobo, Corporate Vice President, Heart Valve Therapy, Corporate Strategy & Corporate Development, Edwards Lifesciences - "Cardiovascular Devices - Where is the Future Taking Us?" |
| 11:30 - 12:10: | Dr. Anthony (Tony) Muslin, Vice President, Head of Cardiovascular and Fibrosis, Sanofi - “Opportunities and Challenges in the Cardiovascular Biopharma Market.” |
| 12:10 - 12: 25: | Magenta Medical |
| 12:25 - 12:40: | DiACardio Ltd |
| 12:40 - 12: 55: | Sensible Medical Innovations Ltd. |
| 13:00-14:00 | Lunch Break |
| 14:00 - 14:15: | Realview Imaging Ltd. |
| 14:15 - 14:30: | Pluristem Therapeutics Inc. |
| 14:30 - 14:45: | ChroniSense Medical Ltd. |
| 14:45 - 15:00: | V-Wave Ltd. |
| 15:15 - 15:45: | Eximo Medical Ltd. |
| 15:45 - 16:00: | Enopace Biomedical Ltd. |
| 16:00 - 16:40: | Amir Lerman, MD, Prof. of Medicine, Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic - "The pathways for creating a biological valve" |
| 16:40 - 17:40: | Panel Discussion: Moderator: Dr. Ehud Cohen, CEO BioControl Panelists: Donald E. Bobo, Corporate Vice President, Heart Valve Therapy, Corporate Strategy & Corporate Development, Edwards Lifesciences Dr. Anthony (Tony) Muslin, Vice President, Head of Cardiovascular and Fibrosis, Sanofi Amir Lerman, MD, Prof. of Medicine, Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic Hila Goldman-Aslan, CEO, Dia Cardio Ltd. |
| WEDNESDAY, MAY 25, 2016 | |
| 08:00-16:00: | Registration Open |
| 09:30-10:10: | Keynote Lecture: Bruce R. Rosengard, MD, Chief Medical Science and Technology Officer, Johnson & Johnson Medical Device Companies |
| 10:10 - 10:40 | Coffee Break |
| 10:40 - 17:30: | From Academia Research to Industry Hall C |
| Chairperson: Shlomo Nimrodi, CEO, Ramot at Tel Aviv University Ltd. | |
| 10:40 - 10:50: | Shlomo Nimrodi - CEO of Ramot - Ramot at Tel Aviv University, Promising Innovations- The impact of academic research on the Israeli eco system |
| 10:50 - 11:10 | Industry perspective - Rabbi Raphael Harrari - Steba BioTech |
| 11:10 – 13:00: | ITTN Startup Competition: BELKIN Laser Ltd. CartiHeal ElMindA Ltd. HBMS MagBiosense Inc. MBcure Nitiloop Ltd. Pam-Bio Ltd. SynVaccine Ltd. TyrNovo Ltd. |
| BELKIN Laser Ltd. | |
| CartiHeal | |
| ElMindA Ltd. | |
| HBMS | |
| MagBiosense, Inc | |
| 13:00-14:00: | Lunch Break |
| 14:00 - 14:20: | Inspiring future medicine- From Bench to bedside Erez Meltzer, Chairman ,Hadassah Hospital and Hadasit, the Technology Transfer Company of Hadassah Medical Organization |
| Erez Meltzer, Chairman ,Hadassah Hospital and Hadasit, the Technology Transfer Company of Hadassah Medical Organization | |
| 14:20 - 15:00: | Big Data in Healthcare: Dr. Liran Shlush, Department of Immunology, Faculty of Biology, Weizmann Dr. Ran Balicer, Director, Health Policy Planning & Director,Clalit Research Institute at Clalit Health Services Chaim Friedman, Managing Partner, LionBird – Venture Capital |
| Dr. Liran Shlush, Department of Immunology, Faculty of Biology, Weizmann | |
| Dr. Ran Balicer, Director, Health Policy Planning & Director,Clalit Research Institute at Clalit Health Services | |
| Chaim Friedman, Managing Partner, LionBird – Venture Capital | |
| 15:00 - 15:40: | Oncology, Cancer Therapy - Current needs and emerging capabilities: Prof. Michal Lotem, Head of Hadassah’s Center for Melanoma and Immunotherapy Prof. Izhak Haviv, Faculty of Medicine, Bar Ilan University Prof. Dan Peer, Cell Research and Immunology, Tel Aviv University |
| Prof. Michal Lotem, Head of Hadassah’s Center for Melanoma and Immunotherapy | |
| Prof. Izhak Haviv, Faculty of Medicine, Bar Ilan University | |
| Prof. Dan Peer, Cell Research and Immunology, Tel Aviv University | |
| 15:40 - 16:20: | Robotics’ Role in Rehabilitation: Dr. Gabi Zeilig, Director of the Department of Neurological Rehabilitation, The Chaim Sheba Medical Center Dr. Orit Raz - The Chaim Sheba Medical Center Dr. Arik Avni – VP Clinical Affairs at Motorika Medical Israel |
| Dr. Gabi Zeilig, Director of the Department of Neurological Rehabilitation, The Chaim Sheba Medical Center | |
| Dr. Orit Raz - The Chaim Sheba Medical Center | |
| Dr. Arik Avni – VP Clinical Affairs at Motorika Medical Israel | |
| 16:20 - 17:00: | Neurological Disorders- from Pessimism to Hope: Dr. Yona Geffen, CEO of Avraham Pharmaceuticals Prof. Abraham Zangen, Head of the Brain Stimulation and Behavior lab at Ben Gurion University |
| Dr. Yona Geffen, CEO of Avraham Pharmaceuticals | |
| Prof. Abraham Zangen, Head of the Brain Stimulation and Behavior lab at Ben Gurion University | |
| 17:00 - 17:30: | Announcement of startup competition winners |